Role of Saraswata Churna with Panchbhautika taila nasya in the management of Autism in children

Evaluation of Saraswata churna with Panchbhautika taila nasya in the management of autism in children- a randomized controlled clinical trial - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/071895

Enrollment

Registered

2024-08-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 03 to 09 years. 2. Diagnosed cases of Autism satisfying DSM 5/ AIIMS Modified INCLEN criteria (INDT- ASD) of either sex 3. Patients with score above 70 in Indian Scale for assessment of Autism (ISAA).

Exclusion criteria

Exclusion criteria: 1. ASD medications from any other system 2. Mental retardation, Cerebral palsy 3. Presence of other organic or psychotic neurological disorder 4. Pervasive developmental disorder 5. Hearing and visual impairment 6. Patients with acute and chronic systemic illness such as renal diseases, Hepatic dysfunction, Juvenile diabetes mellitus etc 7. Congenial disorders, Genetic syndromes like Fragile X syndrome, Turner syndrome etc 8. Progressive and non-progressive neuromuscular disorders 9. Endocrinal disorders, Protein Energy Malnutrition (PEM), Inborn error of metabolism

Design outcomes

Primary

Measure	Time frame
1.Change in ISAA scoreTimepoint: baseline, 3 months	—

Secondary

Measure	Time frame
1.-Change in DSM V criteriaTimepoint: baseline, 3 months	—

Countries

India

Contacts

Public ContactProf Dr Nisha Kumari Ojha

National institute of ayurveda, jaipur

drnishaojha@gmail.com8890072697

Outcome results